We're sorry but this page doesn't work properly without JavaScript enabled. Please enable it to continue.
Feedback

Ascorbic Acid and Cancer

00:00

Formal Metadata

Title
Ascorbic Acid and Cancer
Title of Series
Number of Parts
340
Author
License
CC Attribution - NonCommercial - NoDerivatives 4.0 International:
You are free to use, copy, distribute and transmit the work or content in unchanged form for any legal and non-commercial purpose as long as the work is attributed to the author in the manner specified by the author or licensor.
Identifiers
Publisher
Release Date
Language

Content Metadata

Subject Area
Genre
Abstract
Eight years after he had received a Nobel Prize in Chemistry for his fundamental contributions to stereochemistry, Sir Derek Barton attended the Lindau Nobel Laureate Meetings for the first time. He obviously liked their atmosphere and subsequently returned four times. It’s well worth listening to his talk. It offers a good deal of British pragmatism and humor, combined with the clear and confident sobriety of a scientist, which he also employs to explain why he had chosen a rather nonchemical topic. “This talk was inspired by a letter that I received some years ago from a number of American sociologists who wanted me to write an article how terrible the world was and how we were suffering from the most dreadful crises that mankind had ever suffered from (…) As far as I am concerned, the world is in a better shape than it’s been ever before and I am optimistic about its future and therefore I was pleased to write an article and I was somewhat surprised that this article was never published."Compared to the two World Wars and the big economic depression he had survived, Barton continues, most of the current crises did not appear dramatic to him. He distinguishes three classes of crises: Imaginary, artificial and real crises and then looks at “some of the crises the world press tells us we are suffering from” in terms of these categories. Presently, pollution for example, compared to “the thick, yellow London fog” of former times, appeared to be an imaginary crisis. The energy crisis is an artificial one for Barton, provoked by OPEC’s international monopoly. He is confident that science will find ways to overcome imminent energy shortages. In this context, he criticizes the “almost hysterical reaction in Germany to the proposal of building nuclear power stations”. All other crises he analyzes - global food supply, overpopulation and economic recession – Barton judges for various reasons as still being artificial – except for one: the danger of a nuclear war. While nobody knew exactly how many nuclear devices existed in the world, everybody knew that “it’s quite enough to kill off the population of the world several times.” On a statistical basis, Barton says, there had been at least one or two major wars every century: “Have we the right to believe that suddenly history of mankind is going to change?” Even if the balance of terror prevented the super powers to attack each other, “nuclear weapon technology is going to spread around the world (…) So we are going to come some time to a situation where a country in a last defense will use nuclear weapons or when some mad dictator will get hold of them and will use them in his madness.”Nevertheless, Sir Derek is “modestly optimistic because for the first time in human history we have seen a group of countries come together and give up some of their sacred national sovereignty”. Although it is, as he mentions, not customary in the UK to say something nice about the “Common Market”, he praises the predecessor of the European Union, as if anticipating the Nobel Peace Prize of 2012. Nations ought to have morality. They should learn “to work together in the same way as individuals work together to make up a family group”. If they succeed in doing so, “we may have a chance to evolve”. Joachim Pietzsch
3
Thumbnail
1:06:33
16
Thumbnail
48:23
165
Pauling, LinusChemistryNobeliumChemical bondChemical structureMultiprotein complexPharmaceutical drugTheoretische ChemieNutrientCancerLactitolMeeting/Interview
Pauling, LinusNobeliumChemistryChemical bondMultiprotein complexChemical structureDeathList of causes of death by rateAgeingRiver mouthMeeting/Interview
Pauling, LinusNobeliumChemistryChemical bondChemical structureMultiprotein complexBarton, DerekCancerHyaluronsäureGolgi apparatusRadioactive decayChemotherapyMeeting/Interview
Pauling, LinusNobeliumChemistryChemical bondMultiprotein complexChemical structureBarton, DerekCancerSurvival skillsLactitolMeeting/Interview
Pauling, LinusNobeliumChemistryChemical bondChemical structureMultiprotein complexCancerReaction mechanismMetastasisWine tasting descriptorsBottling lineCell (biology)Controller (control theory)Meeting/Interview
Pauling, LinusChemistryNobeliumChemical bondMultiprotein complexChemical structureBarton, DerekWine tasting descriptorsController (control theory)Reaction mechanismCancerCell (biology)EnzymeHope, ArkansasHyaluronsäureTumorMeeting/Interview
ChemistryPauling, LinusNobeliumChemical bondChemical structureMultiprotein complexBarton, DerekPhysiologyBase (chemistry)InhibitorTumorAbbruchreaktionController (control theory)MixtureCancerMeeting/Interview
ChemistryPauling, LinusNobeliumChemical bondChemical structureMultiprotein complexBarton, DerekAbbruchreaktionCancerOctane ratingISO-Komplex-HeilweiseRiver sourceOrganische ChemieMeeting/Interview
ChemistryPauling, LinusNobeliumChemical bondChemical structureMultiprotein complexBarton, DerekAscorbic acidConnective tissueCancerAcidScarBiosynthesisAageFaserverbundwerkstoffCollisionPolymerGlykolsäureMeeting/Interview
NobeliumChemistryPauling, LinusChemical bondMultiprotein complexChemical structureBarton, DerekConcretionHyaluronsäureShear strengthAscorbic acidCancerController (control theory)ToxinMeeting/Interview
ChemistryPauling, LinusNobeliumChemical bondMultiprotein complexChemical structureBarton, DerekScarAngiotensin-converting enzymeInhibitorAscorbic acidSodiumWine tasting descriptorsMeeting/Interview
NobeliumChemistryPauling, LinusChemical bondMultiprotein complexChemical structureBarton, DerekAscorbic acidReaction mechanismWine tasting descriptorsNutrientCancerRedoxCarbon (fiber)GasMeeting/Interview
Pauling, LinusChemistryNobeliumChemical bondMultiprotein complexChemical structureBarton, DerekImmunologyCancerCell (biology)GesundheitsstörungMoleculeChromosomenaberrationHemoglobinSickleMeeting/Interview
ChemistryNobeliumPauling, LinusChemical bondMultiprotein complexChemical structureBarton, DerekHemoglobinChromosomenaberrationGesundheitsstörungCancerMeeting/Interview
ChemistryPauling, LinusNobeliumChemical bondMultiprotein complexChemical structureBarton, DerekCancerElectronic cigarettePeriodateNicotinamideVitaminNiacinArzneimitteldosisExplosionMeeting/Interview
NobeliumPauling, LinusChemistryChemical bondMultiprotein complexChemical structureBarton, DerekNiacinFoodNutrientFaserplatteAscorbic acidBlind experimentArzneimitteldosisScarAcidAzo couplingMeeting/Interview
ChemistryNobeliumPauling, LinusChemical bondMultiprotein complexChemical structureBarton, DerekAzo couplingAscorbic acidController (control theory)AgricultureGesundheitsstörungConcentrateMeeting/Interview
NobeliumChemistryPauling, LinusChemical bondMultiprotein complexChemical structureGesundheitsstörungVitaminNutrientChemical compoundWursthülleAscorbic acidBattery (electricity)WaterfallConnective tissueLeakOrganische ChemieCollagenJoint (geology)Blood vesselDeathMeeting/Interview
Pauling, LinusNobeliumChemistryChemical bondMultiprotein complexChemical structureBarton, DerekCollagenAscorbic acidVitaminFunctional groupAreaLactitolMeeting/Interview
ChemistryPauling, LinusNobeliumChemical bondChemical structureMultiprotein complexBarton, DerekVitamin B1Chemical plantAzo couplingGrowth mediumVitaminFoodAageAtomMeeting/Interview
Pauling, LinusNobeliumChemistryChemical bondMultiprotein complexChemical structureBarton, DerekChemical plantFoodVitamin B1Ascorbic acidFunctional groupBase (chemistry)GeneCarbon dioxideScarWine tasting descriptorsAcidEnzymeMaterials scienceBody weightSetzen <Verfahrenstechnik>Meeting/Interview
Pauling, LinusNobeliumChemistryChemical bondMultiprotein complexChemical structureBarton, DerekEnzymeThiazoleSetzen <Verfahrenstechnik>PyrimidineSense DistrictVitaminNiacinVitamin B1PyridoxinePH indicatorChemical plantCrack cocaineCarbon dioxideMeeting/Interview
Pauling, LinusNobeliumChemistryChemical bondChemical structureMultiprotein complexBarton, DerekAscorbic acidSpeciesReaction mechanismChemical plantClayFoodCelluloseCollagenMeeting/Interview
NobeliumChemistryPauling, LinusChemical bondMultiprotein complexChemical structureBarton, DerekCarbon dioxideMoleculeProcess (computing)Man pagePrecursor (chemistry)Common landAscorbic acidCollagenChemical plantFoodBody weightAcidMeeting/Interview
Pauling, LinusNobeliumChemistryChemical bondMultiprotein complexChemical structureBarton, DerekEnzymeFoodAscorbic acidScarSetzen <Verfahrenstechnik>Meeting/Interview
ChemistryNobeliumPauling, LinusChemical bondChemical structureMultiprotein complexBarton, DerekBody weightGasAscorbic acidGrowth mediumFoodElephantiasisMeeting/Interview
NobeliumPauling, LinusChemistryChemical bondChemical structureMultiprotein complexBarton, DerekBody weightCancerMeeting/Interview
ChemistryNobeliumPauling, LinusChemical bondMultiprotein complexChemical structureBarton, DerekHematiteGemstoneMedicalizationTube (container)ScarWine tasting descriptorsAssetAscorbic acidMeeting/Interview
Pauling, LinusNobeliumChemistryChemical bondMultiprotein complexChemical structureBarton, DerekAscorbic acidAzo couplingGeneBerylliumTube (container)ElektronentransferAssetFoodMeeting/Interview
ChemistryPauling, LinusNobeliumChemical bondMultiprotein complexChemical structureBarton, DerekKatalaseChromosomeFoodGesundheitsstörungTube (container)Powdered milkNutrientFaserplatteBerylliumRiver mouthMeeting/Interview
NobeliumChemistryPauling, LinusChemical bondMultiprotein complexChemical structureBarton, DerekFeed (film)WursthülleDiet foodMeeting/Interview
Pauling, LinusNobeliumChemistryChemical bondChemical structureMultiprotein complexBarton, DerekAscorbic acidScarBody weightController (control theory)CancerReaction mechanismErdrutschMeeting/Interview
Pauling, LinusNobeliumChemistryChemical bondChemical structureMultiprotein complexBarton, DerekVitalismAscorbic acidFunctional groupScarVitaminNutrientRing strainWursthülleChain (unit)Meeting/Interview
NobeliumChemistryPauling, LinusChemical bondMultiprotein complexChemical structureBarton, DerekRing strainFunctional groupWursthülleErdrutschHomöostaseEnzymeCofactor (biochemistry)AgricultureMeeting/Interview
ChemistryPauling, LinusNobeliumChemical bondChemical structureMultiprotein complexBarton, DerekCofactor (biochemistry)EnzymeGeneAusgangsgesteinCombine harvesterConcentrateGenetic disorderCoalActive siteChromosomenaberrationMeeting/Interview
NobeliumPauling, LinusChemistryChemical bondChemical structureMultiprotein complexBarton, DerekUreaAcidGesundheitsstörungEnzymeCombine harvesterChromosomenaberrationCofactor (biochemistry)AreaVitaminVitamin B12Meeting/Interview
Pauling, LinusChemistryNobeliumChemical bondMultiprotein complexChemical structureBarton, DerekGesundheitsstörungVitaminErdrutschGrowth mediumCofactor (biochemistry)Ascorbic acidBody weightExplosionMeeting/Interview
ChemistryNobeliumPauling, LinusChemical bondMultiprotein complexChemical structureBarton, DerekAscorbic acidHandelsdüngerBody weightScarAcidErdrutschFumigationPig ironMeeting/Interview
ChemistryPauling, LinusNobeliumChemical bondChemical structureMultiprotein complexBiosynthesisWine tasting descriptorsCollagenAscorbic acidLysineHydroxylResidue (chemistry)Chemical reactionScarAcidProlineMoleculeInitiation (chemistry)MedicalizationGesundheitsstörungWoundArzneimitteldosisColumbia RecordsMeeting/Interview
ChemistryPauling, LinusNobeliumChemical bondMultiprotein complexChemical structureBarton, DerekErdrutschArzneimitteldosisSodiumConcentrateAscorbic acidScarGesundheitsstörungController (control theory)CancerExplosionAreaMeeting/Interview
Pauling, LinusChemistryNobeliumChemical bondMultiprotein complexChemical structureBarton, DerekAscorbic acidErdrutschCancerAssetMeeting/Interview
NobeliumPauling, LinusChemistryChemical bondChemical structureMultiprotein complexBarton, DerekSalt (chemistry)FireCarbon dioxideKohlenhydratchemieAcidSerum (blood)Klinisches ExperimentAscorbic acidOctane ratingSystemic therapyMeeting/Interview
Pauling, LinusChemistryNobeliumChemical bondChemical structureMultiprotein complexBarton, DerekCycloheptatrienAscorbic acidGesundheitsstörungErdrutschCarbon (fiber)KorkenTable wineAntibacterialCell (biology)PhagocyteSeparation processWhite blood cellReaction mechanismConcentrateScarFibrocyteMeeting/Interview
ChemistryPauling, LinusNobeliumChemical bondChemical structureMultiprotein complexBarton, DerekCell (biology)Sea levelBlock (periodic table)Rock (geology)Activity (UML)White blood cellProcess (computing)CancerActive siteMeeting/Interview
NobeliumChemistryPauling, LinusChemical bondMultiprotein complexChemical structureSalt (chemistry)Amino acidExplosionComposite materialBiomolecular structureProteinTrace elementMeeting/Interview
NobeliumPauling, LinusChemistryChemical bondChemical structureMultiprotein complexBarton, DerekPig ironEsteraseAscorbic acidErdrutschOctane ratingLymphocyteVolumetric flow rateCancerMeeting/Interview
ChemistryNobeliumPauling, LinusChemical bondChemical structureMultiprotein complexBarton, DerekStimulantOctane ratingCancerAntigenLymphocyteActive siteBiogenesisMeeting/Interview
NobeliumChemistryPauling, LinusChemical bondChemical structureMultiprotein complexBarton, DerekDiet foodSozialepidemiologieAscorbic acidCancerSeparation processErdrutschBET theorySunscreenWine tasting descriptorsMeeting/Interview
NobeliumPauling, LinusChemistryChemical bondChemical structureMultiprotein complexBarton, DerekErdrutschMortality rateGolgi apparatusCigaretteSmoking (cooking)Human subject researchScarWine tasting descriptorsAssetISO-Komplex-HeilweiseSunscreenAscorbic acidMeeting/Interview
NobeliumChemistryPauling, LinusChemical bondChemical structureMultiprotein complexBarton, DerekMortality rateCancerGesundheitsstörungAgeingMeeting/Interview
Pauling, LinusChemistryNobeliumChemical bondChemical structureMultiprotein complexBarton, DerekAscorbic acidNutrientAcidPeriodateWursthülleController (control theory)Drop (liquid)ErdrutschMeeting/Interview
Pauling, LinusNobeliumChemistryChemical bondMultiprotein complexChemical structureBarton, DerekErdrutschCancerWursthülleExplosionAbbruchreaktionActive siteAscorbic acidMedical historyOctane ratingMeeting/Interview
ChemistryNobeliumPauling, LinusChemical bondMultiprotein complexChemical structureBarton, DerekMortality rateOctane ratingCell growthController (control theory)Recreational drug useWursthülleAscorbic acidPainAppetiteMeeting/Interview
NobeliumChemistryPauling, LinusChemical bondMultiprotein complexChemical structureBarton, DerekCell (biology)GesundheitsstörungSedimentationSerum (blood)Red blood cellOctane ratingRapidCancerScarMeeting/Interview
Pauling, LinusNobeliumChemistryChemical bondMultiprotein complexChemical structureBarton, DerekFoodScurvyVitaminGesundheitsstörungBerylliumRecreational drug useAzo couplingCancerAusgangsgesteinMeeting/Interview
NobeliumPauling, LinusChemistryChemical bondChemical structureMultiprotein complexBarton, DerekFireAageErdrutschCancerAbbruchreaktionAscorbic acidMeeting/Interview
Pauling, LinusNobeliumChemistryChemical bondChemical structureMultiprotein complexBarton, DerekController (control theory)Ascorbic acidChemotherapyCancerMatchRecreational drug useToxicityActive siteSurvival skillsSeparation processMeeting/Interview
NobeliumChemistryPauling, LinusChemical bondMultiprotein complexChemical structureBarton, DerekController (control theory)Survival skillsCancerGesundheitsstörungForkhead-GenLeavening agentMeeting/Interview
ChemistryNobeliumPauling, LinusChemical bondChemical structureMultiprotein complexGesundheitsstörungWursthülleCancerSolutionChemotherapyAscorbic acidActive siteRecreational drug useToxicityCarbon (fiber)GasAlopeciaScarScurvyMeeting/Interview
Pauling, LinusChemistryNobeliumChemical bondMultiprotein complexChemical structureBarton, DerekChemotherapyScurvyWursthülleAlopeciaToxicityActive siteWine tasting descriptorsRecreational drug useRiver sourceReaction mechanismSystemic therapyAction potentialMeeting/Interview
NobeliumPauling, LinusChemistryChemical bondChemical structureMultiprotein complexBarton, DerekCancerChemotherapyScurvyLife expectancyAscorbic acidMeeting/Interview
NobeliumChemistryPauling, LinusChemical bondChemical structureMultiprotein complexAscorbic acidCarbon (fiber)CancerChemistGasScurvyWursthülleFoodMeeting/Interview
ChemistryPauling, LinusNobeliumChemical bondMultiprotein complexChemical structureBarton, DerekCancerAscorbic acidMeeting/Interview
Pauling, LinusNobeliumChemistryChemical bondChemical structureMultiprotein complexMeeting/Interview
Transcript: English(auto-generated)
For a number of years I have thought that there should be people who might be said to practice theoretical medicine.
There are thousands of theoretical physicists and they have of course made important contributions to science and hundreds of theoretical chemists, some theoretical biologists, why shouldn't there be people in the field of theoretical medicine.
My experience has indicated that many workers in medicine and such fields as nutrition are not able to understand and appreciate theoretical and rational arguments.
Cancer is one of the most important causes of human suffering. People die of course, they get old and in the course of time die, but the amount of suffering associated with death is different for different causes of death and in fact
for different ages. Death at an advanced age very often involves considerably less suffering for the person himself and for members of his family and others than death at an earlier age.
If we could increase the length of life so that more people died at an advanced age and could eliminate cancer, an especially unpleasant way of dying, then there would be a decrease
in the amount of human suffering. I read a book by a man, Dr. Ewan Cameron of Scotland a number of years ago. The book was published in 1966. Its title is Hyaluronic Acid and Cancer.
He pointed out that not very much progress was being made in the attack on cancer by producing anti-cancer drugs and changing the ways of irradiating a person with high
energy radiation. In fact, the National Cancer Institute has spent billions of dollars, thousands of millions of dollars during the last 20 years, $800 million is its budget this year and yet
the mean survival time of cancer patients has changed very little for a few percent of these patients. With certain rather special kinds of cancer, there has been a significant improvement. But for the great majority, more than 95 percent of the patients who have important
kinds of cancer, there's been essentially no change as a result of all of the effort, all of the expenditure of money. Cameron in his book said that perhaps an effective way of attacking the problem of cancer would
be to bolster up the body's natural protective mechanisms. Many almost every cancer patient after surgery when the primary cancer is removed has millions
of circulating malignant cells and yet not every one of them develops metastases. In many of them, these circulating malignant cells seem to be kept under control.
This is with little doubt the result of an effective immune surveillance. The body's natural protective mechanisms succeed in getting control over the malignant cells and the patient does not succumb to cancer.
Cameron mentioned that malignant cells, many kinds of malignant cells produce the enzyme hyaluronidase, which then attacks the hyaluronic acid in the intercellular cement of the surrounding normal tissues and weakens these tissues in such a way as
to permit infiltration by the malignant tumor. In his book, he went on to express the hope that some way could be found to stimulate
the production by the patient of an increased amount of physiological hyaluronidase inhibitor, which would inhibit the action of the hyaluronidase and in this way protect the surrounding tissues and permit the tumor to be brought under control.
For a number of years, he tried to find some such way by giving to terminal cancer patients various hormones and mixtures of hormones, thinking that sooner or later he might find a hormone that would stimulate the production of a hyaluronidase inhibitor.
And year after year, he was disappointed. The patients with terminal cancer died at just about the rate, the standard rate. There was no effective treatment of this sort.
I was asked in 1971 to give a talk at the dedication of a new laboratory for cancer research at the University of Chicago, the Ben May Laboratory. In fact, Tizelius had been asked to give this address and had agreed to come.
But a week or 10 days before the occasion of the dedication, he sent a telegram saying that he was ill and was not able to come. So the organizers, the people at the Ben May Laboratory called me and asked if I would
come and speak. I needed to say something about cancer, and so I presented an argument as follows. We know one thing about ascorbic acid and have known for 40 years. That is that collagen, the principal component, the proteomatous component of
connective tissue, is not synthesized except in the presence of ascorbic acid. Ascorbic acid is required for its synthesis. The intercellular cement in tissues contains not only these glycosaminoglycans,
hyaluronic acid and long chains, but also long fibrils of collagen, which act like the reinforcing rods in reinforced concrete. They help to strengthen this intercellular cement.
And so I said that I thought that if patients were given more ascorbic acid, this would strengthen the normal tissues and help to bring the malignancy under control. Cameron read a newspaper account of my talk and wrote to me asking how much
ascorbic acid they ought to be given. And I wrote back saying 10 grams per day. He began cautiously giving 10 grams per day of ascorbic acid, actually sodium ascorbate, at first for about 10 days
intravenously and then orally to these patients. And immediately developed the feeling that this was beneficial to the patients. Another argument had been presented at about the same time by Douglas Rotemann who wrote to Cameron saying that
perhaps ascorbic acid units are part of the hyaluronidase inhibitor and perhaps ascorbic acid in large amounts would permit the patient to develop hyaluronidase inhibitor. Well now, of course, we feel that there are many ways
in which an increased intake of ascorbic acid operates to potentiate the body's natural protective mechanisms and perhaps these two that I've mentioned are not the most important ones.
The fact is that it is a matter of observation that patients who receive a good intake of ascorbic acid have a much better prognosis than those who receive just the ordinary intake or less than the ordinary one because, of course,
most cancer patients are malnourished anyway with respect not only to ascorbic acid but to other nutrients. The reason, perhaps I should say, why I said 10 grams per day
but first let me say that it has been a surprise to me to get involved in cancer research. I didn't intend to do it. I was working years ago in the field of immunology for a while and then I had the idea that there could be diseases
that could be described as molecular diseases. Sickle cell anemia was the first disease characterized in that way when it was found that the hemoglobin molecules that patients with this disease manufacture differ from those manufactured by other people
and we found and other people very quickly found a number of other abnormal human hemoglobins a total number known as somewhere around 300. The study of the hemoglobin apathase has extended greatly.
I decided after eight years of working on the hemoglobin apathase to look at other diseases to see to what extent they were molecular diseases and I thought they might as well be it might as well be some important disease.
The choice seemed to me to lie between cancer and mental illness. I decided to study mental illness rather than cancer with the argument back in 1953 this was the argument that almost everybody works on cancer practically nobody works on schizophrenia and other mental diseases
so there wouldn't be so much competition in that field I worked for 10 years on schizophrenia and at the end of that period toward the end of that period I ran across work by Hoffer and Osmond in Canada
on the treatment of schizophrenic patients by giving them large doses of vitamins in particular of nicotinic acid or nicotinamide. I was astonished to read what these investigators reported.
They were giving let's say 17,000 milligrams a day of nicotinic acid to schizophrenic patients whereas 17 milligrams a day is the amount recommended by the Food and Nutrition Board of the United States National Academy of Sciences
National Research Council to prevent pellagra and to keep people in what the Food and Nutrition Board calls ordinary good health. I call it ordinary poor health. Also I found that Milner had carried out
a double-blind study with schizophrenic patients to see what the effect of a large dose of ascorbic acid was and he found a statistically significant effect that a large intake, not very large, a couple of grams per day of ascorbic acid caused the schizophrenic patients to improve
much more than the controls who received a placebo. As I thought about this matter I realized that one might formulate a general principle which is that there is a concentration
of each vital substance that corresponds to the optimum health. This is not necessarily the concentration, the intake that prevents overt manifestations of deficiency disease. It may be very much larger than that.
In fact there is no reason I think to say that only the vitamins are important as nutrients. A vitamin is described as an organic compound that in small amounts is required for life
and good health. And in the case of ascorbic acid if we don't get any ascorbic acid we die of scurvy. The connective tissue just falls apart because collagen is not being synthesized. The joints fall apart and the walls of the blood vessels fall apart.
You have internal intramuscular bleeding all sorts of manifestations ultimately leading to death. Manifestations of degradation of the connective tissue, the collagen. Well, it might be that even without ascorbic acid enough collagen could be synthesized to keep people from dying
and then ascorbic acid would not have been called a vitamin and still the various effects that it has could be very important for good health. I don't think that it is essential that a substance be a nutrient be a vitamin
in order for it to have great importance. But of course ascorbic acid is a vitamin and it's the one that I shall talk about most today. The question comes up why should I recommend 10 grams a day?
Well that seemed a sensible and safe recommendation to make. You know we can ask why is it that all plants manufacture thiamine, vitamin B1 and animals do not manufacture it. They require it exogenously.
The answer is that back several hundred million years ago a plant began running around and eating the other plants and called itself an animal. It was eating its immediate ancestors and they manufacture thiamine and other vitamins
and so it was getting in its food. It wasn't like the red red mold that requires only biotin exogenously and can synthesize everything. This animal it could synthesize ascorbic acid and the plants were making ascorbic acid or thiamine were making thiamine.
It got enough thiamine in its food. Well there is a general basic principle in biology that if you don't need a function then the gene responsible for it disappears and the reason for that of course is that it becomes a burden.
So when a mutant arose which no longer had the genes that synthesized then there are a lot of them involved about 16 perhaps that synthesize the enzymes that convert other materials into thiamine, the pyrimidine half and the thiazole half
and the enzyme that hooks these two together. When the animal a mutant arose that had shuffled off this machinery then he was streamlined. He was not burdened the way the wild type was and consequently the wild type died out and this ancestral animal from then on
he and all of his descendants have required exogenous thiamine in order to be in good health. And this happened for riboflavin and for nicotinic acid and for pyridoxine and vitamin A, the other vitamins. All animals require these substances exogenously.
This is an indication too that the needs of animals for these substances are about the same as for those the needs of the plants. But it didn't happen for ascorbic acid. Practically every animal species as a very good approximation
you can say every animal species has continued to manufacture ascorbic acid. Why didn't this ancestral animal give up the mechanism for manufacturing ascorbic acid? The answer is clear. The amount that the animal was getting in the food was not enough for good health.
Consequently, and we can perhaps understand it, plants don't manufacture collagen. They rely on cellulose as the structural high energy high molecular weight molecule
rather than on collagen. So that this may well be, this perhaps is part of the process of changing from being a plant to an animal that you make great use of collagen and require larger amounts of ascorbic acid. Animals have continued to manufacture ascorbic acid. Man had a bad accident.
The precursor of man, in fact the common precursor of all the primates had a bad accident that of living in too good an environment around 25 million years ago. This environment no doubt was in a tropical valley where the food was especially rich in ascorbic acid.
If you weighed 70 kilograms or if we convert to 70 kilograms body weight there are foods that for 2500 kilocalories or 10,000 kilojoules of energy, food energy can provide as much as 10 grams of ascorbic acid per day.
This was close enough to the optimum to permit the mutant who had lost one enzyme involved in the production of ascorbic acid to shuffle off this, to get rid of this ability and to compete successfully with the wild type
so that he'd replaced him. And since then all of the primates have been in a bad way. Most of them have restricted their habitats to the tropical regions where a good bit of ascorbic acid is available.
Analysis of the food eaten by a gorilla shows that he gets about five grams of ascorbate per day. We moved out into temperate and subarctic regions where the food is not so rich in ascorbic acid and we have been suffering of course
almost all of us from hypoascorbemia ever since. If we ask how much ascorbic acid do animals manufacture? Animals over a 10 million fold range of weight, body weight from the house fly up to the goat say.
I don't think anyone has studied the elephant in this respect. We find that the average amount manufactured by these animals is about 10 grams per day per 70 kilogram body weight. And this is then one of the reasons for saying that this is a reasonable amount to try
to see to what extent it will control cancer. You could use much more. Patients are being given as much as 100 grams a day and have taken I think as much as,
I've heard as much as 400 grams a day without any difficulty. There are thousands of people who have taken several grams a day for years with no overt manifestation of serious side effects, kidney stones and things like this
that are talked about in the medical literature without any sound basis for the suggestion. But 10 grams a day is an amount that it is easy to take. I mentioned the goat. I have, let's see, here in this test tube
which essentially full 13 grams of ascorbic acid. This is the amount that the goat manufactures each day. And would the goat manufacture this if he didn't need it? I don't think so.
This basic general principle would operate if he were to cut down from 13 grams to 12 grams a day he would save 7% of the wear and tear and the energy required to manufacture ascorbic acid. And if that extra one gram were beneficial, why not? Why shouldn't he be saving that effort?
So I think 13 grams a day for a 70 kilogram goat is probably somewhat less. Well, I won't say probably, is somewhat less than the optimum amount. And of course he gets a couple of grams a day in his food too. In this other test tube I have the amount
that a human being manufactures. That's zero. So far as is known, no human beings manufacture ascorbic acid. It's very hard to get back the gene, the ability only by transfer of the gene from some other animal. I understand that a human chromosome is found in cats
of one kind, a sort of European cat, that it's been introduced into the complement, the genetic complement of that animal. But it's hard to get back. Only microorganisms can develop
and under special circumstances too can develop these abilities. In this other test tube, there's a little bit of white powder down in the bottom. That's the 45 milligrams per day that the Food and Nutrition Board in the United States recommends for human beings. It's enough to prevent essentially all people
from getting scurvy, but it is far too small an amount to put people in good health. I think the goat knows more about these matters than the Food and Nutrition Board. In fact, there's another committee of the National Academy of Sciences National Research Council that I think knows more too.
This is the committee on the feeding of laboratory animals. They have made recommendations about monkeys. Monkeys are primates like ourselves and they recommend a diet with somewhere around four grams a day per 70 kilograms of monkey.
Well, now monkeys are expensive and moreover, you might sometimes build up an automated colony of monkeys. It would be very expensive and the monkeys themselves you paid a lot for and you put in a lot of effort to inject the monkeys and do whatever is involved in the experiment
and then they die on you. That's a tragedy. So this committee has gone very carefully into the question of what amount of ascorbic acid will put the monkeys in the best of health and I think I have more confidence in their conclusion that four grams a day per 70 kilogram body weight
is better than 45 milligrams a day. Well, if we do take the proper amount of ascorbic acid and potentiate our natural protective mechanisms, we might well be able to achieve
a considerable control over cancer. I think I might show my slides and amplify the argument as we go on. First slide, please. Here is a curve that I drew showing that with this vital substance such as ascorbic acid,
your well-being might increase linearly for small amounts, small increased intakes and reach optimal functioning at some point. Actually, experiments with especially the red bread mold have shown that curves of this sort have very flat tops when you study nutrients
or vital substances such as the vitamins and you get, it's hard to find just where the optimum is. I have an arrow there, the functioning of the fittest strain. This is corrected for the burden of manufacturing the material
in case that it is manufactured. It is a place where the slope is just equal except for change sign to the straight line, presumably straight line that represents the burden of manufacturing the substance as a function of the amount manufactured. Next slide.
In the next slide, I have just the Michaelis-Menten curve, say chemical equilibrium, A plus B equals AB, which could be enzyme plus substrate, combining to form or the apoenzyme plus the coenzyme combining to form the active enzyme.
And if you have a mutant, everybody is a mutant, the average estimate is that of the 100,000 genes that you've inherited from your parents, one has been mutated from that generation to your generation. Everyone has these mutants.
There may well be people who manufacture apoenzymes with a decreased combination constant for the coenzyme. If the combination constant is decreased 200 times, then you could, by going to 200 times the concentration of the coenzyme,
get the same amount of combination with apoenzyme to form the active enzyme. Well, there are scores of genetic diseases known that involve an abnormality in the combination between constant, between apoenzyme and coenzyme. An example is methylmalonic acid urea.
Patients with this disease excrete methylmalonic acid in the urine because they lack the enzyme that would isomerize the methylmalonic acid to succinic acid, which would then be metabolized. And this enzyme uses cobalamin,
vitamin B12 as the coenzyme. If you give the patient a thousand times the normal intake of cobalamin, then many of the patients are put into normal health and do not show manifestations of the disease.
I think that there are with little doubt thousands of diseases of this sort, each one of which could be controlled by a great increase in the intake of a particular vitamin or other coenzyme.
Next slide. Here, I borrowed this slide from Irwin Stone, who around 10 or 15 years ago was very concerned about the amount of ascorbic acid that people needed and about the prevalence of hypoascorbemia.
It shows various animals have been reported as making between two and 20 grams of ascorbic acid per day per 70 kilogram body weight. Next slide. Here, we have summarized some reasons
for a large intake of ascorbic acid for good health. These animals, the average of raw natural plant foods giving 2,500 kilocalories per day or giving 2,500 kilocalories of food energy is two and three-tenths grams.
And I have an evolution argument, which I shan't go into, that the optimum intake is somewhat greater than this figure. The monkey chow I have mentioned, Dr. Yu studied guinea pigs, which, like the primates, had lost the ability to make ascorbic acid
and found that they were apparently in optimum health when they got about three and a half grams per 70 kilogram body weight. Next slide. I mentioned that ascorbic acid is known to be required for the synthesis of collagen
for hydroxylation of the prolyl and lysyl residues in the pro-collagen molecule, and it's involved in other hydroxylation reactions. For 40 years, it has been known that a high intake of ascorbic acid is required for good healing of wounds
and burns, broken legs, fractures, periodontal disease. Dentists are in the forefront among medical people in giving patients large doses of ascorbic acid to improve their health.
The next slide. Back in 1935, Jungblut in Columbia University College of Physicians and Surgeons reported that poliomyelitis virus is inactivated by sodium ascorbate in concentrations that can be reached in the bloodstream.
Various other investigators have reported the same thing. Next slide, please. I was astonished when I started reading the literature to find how much there is. Here are some of the references, not given in detail, about reported control of viral diseases.
The National Cancer Institute has been spending $100 million a year for a study of viruses in relation to cancer, but zero dollars for an investigation of ascorbic acid as an antiviral agent.
The next slide. And to the extent that viruses are involved in human cancer, the ascorbic acid may be operating in this general antiviral way. The work of Morishige, who is the senior surgeon in a hospital in Fukuoka, Japan,
is interesting. Murata published a paper on it. Morishige had the idea that ascorbic acid would prevent infectious hepatitis, serum hepatitis from developing in surgical patients
who received multiple transfusions with the chance that the virus is in the blood that is infused. He found when he made the study with 1,250 patients that those who got little or no ascorbic acid developed serum hepatitis at the normal,
what was the normal rate there of 7%, but the two grams a day or more is 100% effective in preventing serum hepatitis in 1,100 patients. And now he gives 10 grams a day to all patients in his hospital, all surgical patients,
and all patients in intensive care that he's in charge of. Next slide. And he is reported, but not with the statistics as yet, that in these other viral diseases too, this high intake of ascorbic acid is effective in controlling the viral diseases.
Next slide. Antibacterial action has been reported for many years. There are several mechanisms involved. For one thing, it's been known for 40 years that leukocytes are not effective as phagocytes
unless they have a high concentration, 20 micrograms per 100 million cells of ascorbate. A recent study by Hume and Wiers in Glasgow, 1973, showed that the level was about 25 micrograms
per 100 million cells in the ordinary scots that they investigated. If they came down with some illness, it dropped to about 10. And this is not enough to permit the leukocytes to be effective, to have phagocytic activity.
250 milligrams a day also wasn't enough. One gram a day, however, did the job. Next slide, please. Let's see, I got that in. I put that in at the last minute and apparently put it in reversed,
but I'll tell you, it's upside down too. Perhaps we should change that. Look at this one. At the National Cancer Institute, well, I'll go back to this. Porter.
Rodney Porter has reported in his study of amino acid composition of components of complement that C1, Q, R, and S are proteins which have collagen-like sequences.
Professor George Fagan in Stanford University has carried out these studies. The two curves to the left refer to the C1 esterase component of complement, which consists of these three proteins, Q, R, and S. And as would be expected,
the guinea pigs with a high intake of ascorbic acid manufacture much more of this complement component than those with a low intake. The next slide. Here we have studies made in the National Cancer Institute
reported last year, just in abstract, by Yonamoto, Kratien, and Fehninger showing that the rate of production of new lymphocytes under antigenic stimulation is greatly increased in humans
who are given five grams a day. There's about a doubling of the blastogenesis rate with five grams a day given, in fact, only for three days. And this increase continues for 18 days. They haven't determined what it would be for people
with a steady intake of five grams per day or 10 grams per day. 10 grams a day gives about a tripling. It's well known that the prognosis for cancer patients is better for those who have a high blastogenesis rate
of lymphocytes under antigenic stimulation than for those who have a low one. And these investigators said that these results suggest that ascorbic acid should be tried in cancer patients. They didn't know that Cameron had been doing this for several years. Next slide, please.
There's a good bit of epidemiological information about ascorbic acid. In fact, when studies are made of the diets of populations in relation to incidents of cancer of different kinds, it is usually found
that the biggest correlation of all is the inverse correlation with intake of ascorbic acid. I've written down some of the papers, mentioned some of the papers in this field. The next slide.
There was a study carried out in California, Choop and Breslau with 577 older people starting in 1958. They were all 50 years or older at that time and their death rates were followed. Those with a higher intake, here again the biggest correlation, negative,
between death rate and NA factor was with the intake of ascorbic acid. Even a bigger effect with cigarette smoking. The subjects who were ingesting the larger amount of ascorbic acid had only 40% the age-corrected death rate of those with the smaller amount.
The larger amount was only about 125 milligrams a day. The smaller amount, 25 milligrams a day. We are checking a population now with an intake of between one and two grams a day and in a few years, well, there are already some preliminary results.
For the first 18 months, that result was only a 30%. In fact, this population wasn't restricted to those between one and two grams, contained some with a smaller intake. Only 30% to the age-corrected death rate.
There was apparently the same decrease in the incidence of heart disease as of cancer and other diseases in these studies. I think that it may well be that the age-corrected death rate could be reduced to two-tenths of what it is in the population at present
simply by increasing the intake of ascorbic acid and perhaps other nutrients by a relatively small amount. Next slide. And that would correspond to increase of 20 years or more in the length of the period of well-being.
Two papers have appeared recently on control of polyps of the rectum which universally become malignant in the people who have this chronic polyposis. And in each case with only three grams per day given to the patients, the half of them showed the disappearance of the polyps.
Instead of having 40 of them, they dropped to zero or two. The next slide. Here we have the first report by Cameron on the first 50 cases of patients with terminal cancer,
advanced terminal cancer called untreatable cancer in Scotland. The statement is made that in four cases the treatment with ascorbic acid was harmful. As I've looked over the data and the case histories,
I concluded that this probably is not correct because these patients, the population of 50 or the population of 100, including this 50, died off during the first few days or the first few weeks at a lower rate than the control population.
There was really no increased death rate in this first 50. The fact that these patients died during the first two weeks, four of them, I think indicated to Cameron and Campbell that the ascorbate was harmful.
In all of the other cases there was benefit and the benefit was sometimes a rather small amount to decrease in pain, permitting the patients to be taken off narcotic drugs or general disappearance of cachexia and anorexia.
Patients felt well and had good appetites, began to eat well, went back to work and some of them have continued to live. The next slide, far longer than expected. One patient showed an unusual course
such as to permit him to be described in a separate publication. He had reticulum cell sarcoma, well diagnosed by biopsy and the x-ray diagrams showed that this disease was there. When he received 10 grams a day of ascorbate, he improved very rapidly
as shown by these measures of illness. A decreased sedimentation rate of red cells was observed and glycosaminoglycan serum zero muclide decreased rapidly. After six months his physician took him off the vitamin C, 10 grams a day with the argument that he was cured,
no signs of disease anymore so he shouldn't continue taking the drug. Well of course vitamin C isn't a drug, it is a food and he was taking the amount that probably is just appropriate to human beings. If they were manufacturing it themselves, the amount they would manufacture. He took him off the vitamin C and within a month
he was back in the hospital, the cancer returned. It didn't respond to 10 grams per day orally when it was resumed for a couple of weeks but he was given 20 grams a day for 10 days intravenously and immediately improved in health
and he has lived now for several years getting 12 and a half grams a day orally and driving his lorry back and forth apparently in perfect health. Well it's good health perhaps even better than you expect for people 50 years old
living in Scotland. The next slide shows the results of a study of 1100 patients with terminal cancer. A hundred of whom received 10 grams of ascorbate per day beginning on the day that they were pronounced untreatable.
This may occur at laparotomy when the cancer is observed to be of such a nature that it is inoperable or later after high energy radiation treatment or cytotoxic drugs have been tried
and perhaps had some temporary value but are no longer effective. The matched controls, 10 matched controls for each of the 100 ascorbate treated patients had the same kind of cancer and the survival times are measured again
from the time when they were considered untreatable. The 50 times the fraction of the ascorbate treated patients lived more than a year. The 16 out of 100 of the ascorbate treated patients are alive after several years
as much as over five and a half years now. The average survival time now is more than five times the average survival time of the 100 controls, the 1000 controls. The 1000 controls have all died by this time with only 15 out of 1000 living more than one year.
No, only, yes, I think 15 is right. Only three, three out of 1000 lived more than a year. It's marked as 400 days there. Now several hundred patients with cancer
are receiving 10 grams per day in veil of leaving hospital in Scotland and they begin to receive it immediately that they come to the hospital no matter what the stage of development of the disease is. I could go on and mention some individual cases
not only in Scotland but also in California but this is the only quantitative material that I have. I think that every cancer patient should be put on ascorbic acid therapy.
What the relation is to the cytotoxic drugs has not yet been carefully studied. In California, patients who are receiving five-fluorouracil or methotrexate or other cytotoxic drugs have been given ascorbic acid also 10 grams a day
and one observation has been made in practically every case the serious side effects of loss of hair and nausea, other side effects of the cytotoxic drugs do not show up when vitamin C is given. On the other hand, it may be that
these two treatments operate against one another. The cytotoxic drugs have the side effect of destroying the body's natural protective mechanisms and the vitamin C operates by potentiating the body's natural protective mechanisms.
If you knock out the immune system down to zero tenfold or a hundredfold potentiation still leaves it at zero. In the course of time, it will be possible to say what should be done when the choice arises between taking cytotoxic drugs or taking vitamin C.
But there is reason to believe that whether or not these other treatments are used the vitamin C should be taken. Well, this is the situation now. I haven't found anything in the cancer literature during the last 20 years that is comparable to this.
To what extent it will stand up whether you can have a five-fold increase in life expectancy for people at the beginning stages of cancer who might have a five-year life expectancy that would be increased to 25 years with ascorbate or not.
I don't know. I do feel strongly that cancer and ascorbic acid are closely related. It may be that cancer is in large part one of the manifestations of vitamin C deficiency.
That people develop cancer because they are in poor health because of the extremely small amount of ascorbic acid that they ingest. Of course, I have read statements that chemicals which have been introduced into our environment
in our food and into the environment generally are responsible for a large fraction of the cases of cancer that develop. Ascorbic acid is known to be a detoxifying agent for almost all substances and perhaps it can work or does work
as a prophylactic agent by helping to counteract the effect of these cancerogenic substances. I think that this opportunity of helping to control cancer by the use of the proper amount of ascorbic acid
both prophylactically and people who have not yet developed cancer and therapeutically and those who have is so important that it should not be neglected by anyone. Thank you.